Product Overview
Certara’s Quantitative Systems Pharmacology (QSP) software is an advanced platform that enhances biopharmaceutical R&D. By integrating computational modeling with experimental data, it helps drug developers predict efficacy and safety outcomes, explore therapeutic strategies, and make informed decisions during the drug development process. Our regulatory-ready QSP software provides reproducible models that are trusted by global regulators, including the FDA, EMA, and PMDA.
Accelerate drug development with advanced mechanistic modeling
Certara’s QSP Software is designed to address the most complex challenges in drug discovery and development. The platform uses big data and quantitative systems pharmacology for dynamic modeling of biological pathways, drug interactions, and disease processes. This comprehensive approach empowers researchers to predict clinical outcomes, optimize dosing regimens, and accelerate time-to-market for innovative therapies.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
- Predictive insights for efficacy and safety: Simulate drug effects across diverse populations, accounting for genetic, biological, and pharmacological variability.
- Streamlined decision-making: Leverage evidence-based models to prioritize compounds and determine go/no-go milestones.
- Integration with PBPK models: Combine QSP and PBPK modeling for a robust understanding of drug behavior and response.
- Regulatory-ready modeling for global compliance: Certara’s QSP Software meets the rigorous standards of global regulatory agencies, ensuring reproducibility and reliability in model-based submissions.
About the company
We transform drug development for the benefit of humans. Our commitment is to empower innovators, researchers, and regulatory experts with software and service solutions tailored exactly to meet their needs, fostering success across the entire drug development lifecycle.
Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, scientific, strategic and regulatory expertise to create a future where treatments reach patients faster and more efficiently.
